Hanna Baurska
Overview
Explore the profile of Hanna Baurska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baurska H, Kielbinski M, Biecek P, Haus O, Jazwiec B, Kutner A, et al.
Leuk Res
. 2014 Apr;
38(5):638-47.
PMID: 24703772
The differentiation-inducing potential of side-chain modified analogs of vitamins D, compared to the reference compound, 1,25-dihydroxyvitamin D3, was studied in blast cells from patients with acute myeloid leukemia and in...
2.
Gocek E, Baurska H, Marchwicka A, Marcinkowska E
Leuk Res Treatment
. 2012 Dec;
2012:713243.
PMID: 23213549
1α,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D) exerts its biological activities through vitamin D receptor (VDR), which is a member of the superfamily of steroid receptors, that act as ligand-dependent transcription factors. Ligated VDR...
3.
Gocek E, Marchwicka A, Baurska H, Chrobak A, Marcinkowska E
J Steroid Biochem Mol Biol
. 2012 Jul;
132(3-5):220-6.
PMID: 22789609
Some leukemic cell lines can be driven to differentiate to monocyte-like cells by 1,25-dihydroxyvitamin D(3) (1,25D) and to granulocyte-like cells by all-trans retinoic acid (ATRA). Acute myloid leukemias (AMLs) are...
4.
Baurska H, Marchwicka A, Klopot A, Kutner A, Marcinkowska E
Oncol Rep
. 2012 Jul;
28(3):1110-6.
PMID: 22751936
1,25-Dihydroxyvitamin D3 (1,25D) is implicated in many cellular functions including cell proliferation and differentiation, thus, exerting potential antitumor effects. A major limitation for therapeutic use of 1,25D are its potent...
5.
Gocek E, Kielbinski M, Baurska H, Haus O, Kutner A, Marcinkowska E
Leuk Res
. 2009 Nov;
34(5):649-57.
PMID: 19880182
This study was designed to compare the differentiation-inducing potential of 1,25-dihydroxyvitamin D(3) (1,25D) with some analogs (VDAs) in a panel of acute myeloid leukemia (AML) cell lines and in blast...